Awards Registry

Flexible Integrated Simulation Architecture – Execute Module
Profile last edited on: 7/30/2021

Program
SBIR
Agency
MDA
Total Award Amount
$1,136,366
Award Phase
2
Principal Investigator
M Douglas Williams
Activity Indicator

Company Information

Seed Innovations LLC

19960 Capella Drive
Monument, CO 80132
   (719) 368-4040
   info@seed-innovations.com
   www.seed-innovations.com
Multiple Locations:   
Congressional District:   05
County:   El Paso

Phase I

Phase I year
2020
Phase I Amount
$150,000
Seed Innovations proposes to design and develop a proof-of-concept system, the Automatic Generation of Application Vulnerability Mitigations (AGAVM), that will automatically generate source code level mitigations to potential vulnerabilities in application software based on weaknesses identified by commercial-off-the- shelf (COTS) static code analysis tools. AGAVM features a plug-in architecture, applies modern techniques including inference, automatic code generation, machine leaning (ML) and artificial intelligence (AI) methods for recognizing and mitigating software vulnerabilities at the source code level to help ensure the integrity of military information infrastructure and help protect the warfighter against cyber threats. Approved for Public Release | 19-MDA-10270 (18 Nov 19)

Phase II

Phase II year
2020 (last award dollars: 2020)
Phase II Amount
$986,366
Seed Innovations will design and develop a prototype system, the Flexible Integrated Simulation Architecture – Execute Module (FISA-EM). The purpose of FISA-EM is to automate the provisioning of simulation environments and the configuration of simulation models to enable deployment into distributed environments. In the development of the FISA prototype, Seed Innovations applies modern software techniques including automatic code generation, modern interface definition techniques, and containerization of executables in support of developing and executing complex simulations. FISA-EM enables evolution from manual processes to automated deployments. Approved for Public Release | 20-MDA-10482 (18 May 20)